Skip links

News

Mexico Flag

PharmaCielo Announces First Shipment to Mexican Joint Venture Partner

August 4, 2022 The Company has made a pre-commercial shipment of CBD isolate to its Mexican joint venture, to support product development by a Mexican phytotherapeutic company. TORONTO, Canada and RIONEGRO, Colombia (August 4, 2022) – PharmaCielo Ltd. (“PharmaCielo” orthe “Company”) (TSXV: PCLO, OTCQX: PCLOF),

PharmaCielo Signs Sales Agreement with Greenstein to Supply THC Final Products that will be Commercialized through NOWEDA, a Pharmaceutical Wholesaler to all Pharmacies Across Germany

February  14, 2022 The Company will start supplying the German market with three THC-dominant products, with commercial shipments expected to begin in late 2022. This is PharmaCielo’s first sales agreement related to THC products. Represents a significant milestone related to management’s re-focusing of PharmaCielo’s product